We then analyzed CLEC4G expression levels in these positive cells and found that the control group exhibited significantly higher expression levels compared to the AD group (p = 0.0186, Figure S1C), a finding consistent with the results obtained from bulk RNA-seq analysis. This evidence concerns the gene CLEC4G and Alzheimer disease.